Suggestions
Daniel Pharand
Co-Founder at Hubermed Inc
Professional Background
Daniel Pharand is a highly accomplished professional in the biotech and healthcare sectors, with a robust track record that showcases his expertise in financial management and strategic leadership. As a co-founder of Hubermed Inc, he has been instrumental in steering the direction of the company, contributing his extensive experience in venture management and biotechnology. Daniel's career reflects a remarkable journey through some of the industry's leading organizations, where he has played pivotal roles in enhancing operational efficiency and driving growth.
Before co-founding Hubermed Inc, Daniel served as the Chief Financial Officer (CFO) at Cato Research, where he oversaw financial operations and contributed to the company's strategic planning. His previous experiences also include being a Principal at Cato BioVenture, where he leveraged his financial acumen to support the growth of emerging biotech companies. His role as Managing Director Biotech at Innovatech Grand Montreal further solidified his reputation in the industry, where he fostered innovation and collaboration within the biotech community.
Education and Achievements
Daniel Pharand studied at Concordia University, where he earned his Bachelor of Commerce degree with Cum Laude honors. His rigorous academic background provided him with a strong foundation in business and finance, which has been critical in his professional career. With a keen understanding of financial strategies and market dynamics, he has consistently driven success and delivered value across various organizations.
In addition to his role as CFO at major firms like Pharmacia kk and Pharmacia Canada, he also began his journey in finance at Price Waterhouse, where he gained invaluable experience that set the stage for his future endeavors. Throughout his career, Daniel has demonstrated exceptional leadership skills and a commitment to fostering growth within the biotech sector, making significant contributions to the companies he has been associated with.
Achievements
Daniel's professional milestones have positioned him as a leader in the biotech industry. His tenure at multiple firms has been marked by successful financial governance, strategic fundraising efforts, and the ability to lead teams through complex regulatory landscapes. His leadership at Cato Research was particularly noteworthy, as he implemented rigorous financial systems that strengthened the company’s position in the competitive biotech arena.
Having worked with renowned companies, Daniel has cultivated a network of professionals that spans across the life sciences and financial sectors. He continues to be a respected figure among his peers, not only for his business acumen but also for his commitment to mentoring the next generation of leaders in the industry. Daniel's impact on the biotech landscape is significant, and his ongoing work at Hubermed Inc positions him as a key player in advancing healthcare solutions that benefit society at large.
